ZA95756B - Macrocyclic difluorostatone derivatives useful as antiviral agents - Google Patents
Macrocyclic difluorostatone derivatives useful as antiviral agentsInfo
- Publication number
- ZA95756B ZA95756B ZA95756A ZA95756A ZA95756B ZA 95756 B ZA95756 B ZA 95756B ZA 95756 A ZA95756 A ZA 95756A ZA 95756 A ZA95756 A ZA 95756A ZA 95756 B ZA95756 B ZA 95756B
- Authority
- ZA
- South Africa
- Prior art keywords
- pct
- hiv
- antiviral agents
- macrocyclic
- useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Public Health (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- AIDS & HIV (AREA)
- Engineering & Computer Science (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19208094A | 1994-02-04 | 1994-02-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA95756B true ZA95756B (en) | 1995-10-05 |
Family
ID=22708156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA95756A ZA95756B (en) | 1994-02-04 | 1995-01-31 | Macrocyclic difluorostatone derivatives useful as antiviral agents |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5969132A (pt) |
| EP (1) | EP0742791B1 (pt) |
| JP (1) | JP3574455B2 (pt) |
| KR (1) | KR100367379B1 (pt) |
| CN (1) | CN1142830A (pt) |
| AT (1) | ATE198602T1 (pt) |
| AU (1) | AU684875B2 (pt) |
| CA (1) | CA2182476C (pt) |
| DE (1) | DE69426574T2 (pt) |
| DK (1) | DK0742791T3 (pt) |
| ES (1) | ES2155515T3 (pt) |
| FI (1) | FI963073A0 (pt) |
| GR (1) | GR3035623T3 (pt) |
| HU (1) | HUT74384A (pt) |
| IL (1) | IL112514A0 (pt) |
| NO (1) | NO963254L (pt) |
| NZ (1) | NZ277410A (pt) |
| PT (1) | PT742791E (pt) |
| WO (1) | WO1995021186A1 (pt) |
| ZA (1) | ZA95756B (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2338789T3 (es) | 2003-06-18 | 2010-05-12 | Tranzyme Pharma Inc. | Antagonistas macrociclicos del receptor de motilina. |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH672792A5 (pt) * | 1985-02-19 | 1989-12-29 | Sandoz Ag | |
| EP0218688B1 (en) * | 1985-04-19 | 1990-09-12 | The Upjohn Company | Dihalo-statine substituted renin inhibitors |
| WO1990000399A1 (en) * | 1988-07-08 | 1990-01-25 | Smithkline Beckman Corporation | Retroviral protease binding peptides |
| US5071837A (en) * | 1990-11-28 | 1991-12-10 | Warner-Lambert Company | Novel renin inhibiting peptides |
| CA2098020C (en) * | 1991-01-02 | 2003-10-21 | Daniel Schirlin | Anti-viral compounds |
| HUT76648A (en) * | 1994-07-15 | 1997-10-28 | Merrell Pharma Inc | Difluorostatone, pharmaceutical compositions containing them and process for producing them |
-
1994
- 1994-11-28 WO PCT/US1994/013711 patent/WO1995021186A1/en active IP Right Grant
- 1994-11-28 AT AT95903633T patent/ATE198602T1/de not_active IP Right Cessation
- 1994-11-28 US US08/676,208 patent/US5969132A/en not_active Expired - Fee Related
- 1994-11-28 EP EP95903633A patent/EP0742791B1/en not_active Expired - Lifetime
- 1994-11-28 HU HU9602158A patent/HUT74384A/hu unknown
- 1994-11-28 JP JP52059495A patent/JP3574455B2/ja not_active Expired - Fee Related
- 1994-11-28 CN CN94194939A patent/CN1142830A/zh active Pending
- 1994-11-28 PT PT95903633T patent/PT742791E/pt unknown
- 1994-11-28 AU AU12622/95A patent/AU684875B2/en not_active Ceased
- 1994-11-28 NZ NZ277410A patent/NZ277410A/en unknown
- 1994-11-28 DK DK95903633T patent/DK0742791T3/da active
- 1994-11-28 ES ES95903633T patent/ES2155515T3/es not_active Expired - Lifetime
- 1994-11-28 KR KR1019960704227A patent/KR100367379B1/ko not_active IP Right Cessation
- 1994-11-28 DE DE69426574T patent/DE69426574T2/de not_active Expired - Fee Related
- 1994-11-28 CA CA002182476A patent/CA2182476C/en not_active Expired - Fee Related
-
1995
- 1995-01-31 ZA ZA95756A patent/ZA95756B/xx unknown
- 1995-02-01 IL IL11251495A patent/IL112514A0/xx unknown
-
1996
- 1996-08-02 FI FI963073A patent/FI963073A0/fi not_active IP Right Cessation
- 1996-08-02 NO NO963254A patent/NO963254L/no not_active Application Discontinuation
-
2001
- 2001-03-23 GR GR20010400468T patent/GR3035623T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0742791B1 (en) | 2001-01-10 |
| DE69426574T2 (de) | 2001-08-09 |
| NO963254D0 (no) | 1996-08-02 |
| HU9602158D0 (en) | 1996-09-30 |
| CN1142830A (zh) | 1997-02-12 |
| JP3574455B2 (ja) | 2004-10-06 |
| AU1262295A (en) | 1995-08-21 |
| PT742791E (pt) | 2001-06-29 |
| WO1995021186A1 (en) | 1995-08-10 |
| DE69426574D1 (de) | 2001-02-15 |
| NZ277410A (en) | 1997-02-24 |
| IL112514A0 (en) | 1995-05-26 |
| NO963254L (no) | 1996-08-02 |
| CA2182476C (en) | 2000-12-26 |
| KR100367379B1 (ko) | 2003-04-11 |
| JPH09508417A (ja) | 1997-08-26 |
| FI963073A (fi) | 1996-08-02 |
| ES2155515T3 (es) | 2001-05-16 |
| EP0742791A1 (en) | 1996-11-20 |
| GR3035623T3 (en) | 2001-06-29 |
| DK0742791T3 (da) | 2001-04-02 |
| AU684875B2 (en) | 1998-01-08 |
| US5969132A (en) | 1999-10-19 |
| FI963073A0 (fi) | 1996-08-02 |
| HUT74384A (en) | 1996-12-30 |
| ATE198602T1 (de) | 2001-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG102048A (en) | Tetrahydrofuran-containing sulphonamides as aspartylprotease inhibitors | |
| IL112841A0 (en) | Sulfonamide aspartyl protease inhibitors methods for the preparation thereof and pharmaceutical compositions containing the same | |
| WO1990015066A3 (fr) | Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in vitro des infections dues a ces virus | |
| SI0887427T1 (sl) | Pomnozevanje in detekcija HIV-1 in/ali HIV-2 | |
| BG100455A (en) | Hiv protease inhibitors | |
| MX9706913A (es) | Compuestos de bis-aminacido-hidroxietilamina-sulfonamida inhibidoresde proteasan retroviral, composiciones que los contienen y ek uso de los mismos. | |
| MX9706947A (es) | Inhibidores de proteasa retroviral de sulfonilalcanoilamino-hidroxietilamino-sulfonamida y uso de los mismos. | |
| HUP0202502A2 (hu) | Virális fertőzőképességet blokkoló peptidek és eljárások ezek alkalmazására | |
| BR9607625A (pt) | Inibidores de protease retroviral sulfonamida hidroxietilamino de aminoácido heterociclocarbonila | |
| MX9700414A (es) | Agentes antivirales de difluoroestatona. | |
| ES2123156T3 (es) | Compuestos y procedimientos de inhibicion de hiv y virus semejantes. | |
| MY126450A (en) | Crystalline efavirenz | |
| GR3024226T3 (en) | Antiviral naphthoquinone compounds, compositions and uses thereof. | |
| ZA95756B (en) | Macrocyclic difluorostatone derivatives useful as antiviral agents | |
| UA41338C2 (uk) | Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл) | |
| MXPA04004061A (es) | Derivados de quinolina y piridina antiretrovirales. |